Fig A1.

(A) Dot plot of the average number of months between physician (MD) visits (months of progression-free survival [PFS]/number of medical oncology, surgical, or dermatologic visits in patients who had melanoma with resectable versus unresectable first relapses; P = .63, not significant). Data are calculated as total number of medical oncology, surgical, or dermatologic visits divided by total months of PFS. (B) Dot plot of the number of months from last MD visit until first relapse (P = .4, not significant). First recurrences before the next scheduled MD visit were detected by symptoms. Data were available for 72% of patients. Horizontal lines indicate median values.